Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 88
Filtrar
1.
Toxicol Appl Pharmacol ; 414: 115428, 2021 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-33524449

RESUMEN

Researches have shown that calcitonin gene-related peptide (CGRP) plays a pivotal role in pain modulation. Nociceptive information from the periphery is relayed from parabrachial nucleus (PBN) to brain regions implicated involved in pain. This study investigated the effects and mechanisms of CGRP and CGRP receptors in pain regulation in the PBN of naive and neuropathic pain rats. Chronic sciatic nerve ligation was used to model neuropathic pain, CGRP and CGRP 8-37 were injected into the PBN of the rats, and calcitonin receptor-like receptor (CLR), a main structure of CGRP receptor, was knocked down by lentivirus-coated CLR siRNA. The hot plate test (HPT) and the Randall Selitto Test (RST) was used to determine the latency of the rat hindpaw response. The expression of CLR was detected with RT-PCR and western blotting. We found that intra-PBN injecting of CGRP induced an obvious anti-nociceptive effect in naive and neuropathic pain rats in a dose-dependent manner, the CGRP-induced antinociception was significantly reduced after injection of CGRP 8-37, Moreover, the mRNA and protein levels of CLR, in PBN decreased significantly and the antinociception CGRP-induced was also significantly lower in neuropathic pain rats than that in naive rats. Knockdown CLR in PBN decreased the expression of CLR and the antinociception induced by CGRP was observably decreased. Our results demonstrate that CGRP induced antinociception in PBN of naive or neuropathic pain rats, CGRP receptor mediates this effect. Neuropathic pain induced decreases in the expression of CGRP receptor, as well as in CGRP-induced antinociception in PBN.


Asunto(s)
Analgésicos/farmacología , Péptido Relacionado con Gen de Calcitonina/farmacología , Proteína Similar al Receptor de Calcitonina/agonistas , Dolor Nociceptivo/prevención & control , Umbral del Dolor/efectos de los fármacos , Núcleos Parabraquiales/efectos de los fármacos , Fragmentos de Péptidos/farmacología , Receptores de Péptido Relacionado con el Gen de Calcitonina/agonistas , Ciática/prevención & control , Animales , Proteína Similar al Receptor de Calcitonina/genética , Proteína Similar al Receptor de Calcitonina/metabolismo , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Masculino , Dolor Nociceptivo/genética , Dolor Nociceptivo/metabolismo , Dolor Nociceptivo/fisiopatología , Núcleos Parabraquiales/metabolismo , Núcleos Parabraquiales/fisiopatología , Ratas Sprague-Dawley , Receptores de Péptido Relacionado con el Gen de Calcitonina/genética , Receptores de Péptido Relacionado con el Gen de Calcitonina/metabolismo , Ciática/genética , Ciática/metabolismo , Ciática/fisiopatología
2.
Behav Brain Res ; 443: 114351, 2023 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-36804439

RESUMEN

The present study has explored the role of calcitonin gene-related peptide (CGRP) and its receptor in inflammatory pain modulation in arcuate nucleus of hypothalamus (ARC). Our study demonstrated that intra-ARC injection of CGRP induced antinociceptive effects to naïve rats and rats with inflammatory pain, the effect could be inhibited by the selective CGRP receptor antagonist CGRP8-37. Interestingly, the CGRP-induced antinociception effect was decreased in rats with inflammatory pain compared to naïve rats. Similarly, we found that calcitonin receptor like receptor (CLR), a main component of CGRP receptor, had a low decreased expression levels in the ARC regions of rats with inflammatory pain. The CGRP-induced antinociceptive effect was significantly impaired after reducing CLR expression by intra-ARC administration of CLR targeted siRNA. These findings demonstrated that CGRP might play a crucial role in nociceptive modulation in the ARC during inflammatory pain, which was mediated by CGRP receptor in the ARC. This study shed light upon CGRP and its receptor interaction might be valuable strategies for the alleviation of inflammatory pain.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina , Receptores de Péptido Relacionado con el Gen de Calcitonina , Animales , Ratas , Analgésicos/efectos adversos , Núcleo Arqueado del Hipotálamo/metabolismo , Péptido Relacionado con Gen de Calcitonina/metabolismo , Péptido Relacionado con Gen de Calcitonina/farmacología , Nocicepción , Dolor/metabolismo , Receptores de Péptido Relacionado con el Gen de Calcitonina/metabolismo
3.
J Neurosci Res ; 88(7): 1595-604, 2010 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-20091775

RESUMEN

A major goal of research on drug addiction is to develop the effective treatments to deal with the long-term behavioral disorders especially reinstatement induced by the addictive drugs such as opiates, cocaine, and cannabinoid. The molecular mechanisms underlying these substance-related disorders remain unclear so far. Here we used the model of morphine-induced conditioned place preference (CPP) in rats to mimic the progress of drug-taking, withdrawal and relapse in human. The tissue of ventral tegmental area (VTA), one of the most important brain structures associated with abused drug-related disorders, was taken and two-dimensional electrophoresis (2-DE) was performed to analyze and compare the changes of protein expression patterns during the different stages of morphine-induced CPP. First, we found that there were 80 proteins identified to be changed in the process of morphine-induced CPP. Furthermore, as the mitogen-activated protein kinase kinase 1 (MAPKK1) was increased significantly in the stages of establishment and reinstatement, we confirmed the change of activated extracellular signal-regulated kinase (ERK) by Western blotting in VTA tissue and cultured cell. The results demonstrated that the activated MEK-ERK pathway by chronic morphine treatment in VTA was involved in morphine-induced reinstatement. Moreover, inhibition of MEK-ERK pathway by infusion the MEK inhibitor U0126 in VTA blocked the establishment of morphine-induced CPP. The present study found significant changes in a group of protein expressions in VTA during morphine-induced CPP and further confirmed the role of MEK-ERK cell signaling pathway of VTA in morphine addiction.


Asunto(s)
Condicionamiento Psicológico/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Dependencia de Morfina/metabolismo , Morfina/farmacología , Área Tegmental Ventral/efectos de los fármacos , Área Tegmental Ventral/metabolismo , Animales , Condicionamiento Psicológico/fisiología , Modelos Animales de Enfermedad , Inhibidores Enzimáticos/farmacología , MAP Quinasa Quinasa 1/efectos de los fármacos , MAP Quinasa Quinasa 1/metabolismo , Sistema de Señalización de MAP Quinasas/fisiología , Masculino , Proteína Quinasa 3 Activada por Mitógenos/efectos de los fármacos , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Dependencia de Morfina/fisiopatología , Narcóticos/farmacología , Ratas , Ratas Wistar
4.
Bioessays ; 30(6): 606-10, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18478541

RESUMEN

Single-cell microinjection has been successfully used to deliver exogenous proteins, cDNA constructs, peptides, drugs and particles into transfection-challenged cells. With precisely controlled delivery dosage and timing, microinjection has been used in many studies of primary cultured cells, transgenic animal production, in vitro fertilization and RNA inference. This review discusses the advantages and limits of microinjection as a mechanical delivery method and its applications to attached and suspended cells.


Asunto(s)
Técnicas Citológicas/métodos , Microinyecciones , Animales , Adhesión Celular , Células Cultivadas , Técnicas Citológicas/instrumentación , Colorantes Fluorescentes , Técnicas Genéticas/instrumentación , Humanos , Microinyecciones/instrumentación , Neuronas/citología , Transducción Genética
5.
Front Pharmacol ; 11: 928, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32670060

RESUMEN

It is known that calcitonin gene-related peptide (CGRP) plays a key role in pain modulation in the brain. There are high expressions of CGRP and CGRP receptor in anterior cingulate cortex (ACC), an important brain structure in pain modulation. The present study explored the role and mechanisms of CGRP and CGRP receptor in nociceptive modulation in ACC in naïve rats and inflammatory rats. Administration of different does of CGRP in ACC induced significant antinociception in a dose-dependent manner in both naïve rats and rats with inflammatory pain. The CGRP-induced antinociception was attenuated by injection of the CGRP receptor antagonist CGRP8-37 in ACC. Interestingly, both CGRP-induced antinociception and CGRP receptor expression decreased in ACC in rats with inflammatory pain compared with naïve rats. Knockdown of CGRP receptor in ACC by siRNA targeting to CGRP receptor attenuated both the CGRP receptor expression and the CGRP-induced antinociception significantly in rats. These findings demonstrate that CGRP and CGRP receptor participate in nociceptive modulation in ACC in rats, inhibiting CGRP receptor expression induces decrease in CGRP-induced antinociception in ACC.

6.
Curr Opin Biotechnol ; 19(5): 506-10, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18725294

RESUMEN

Microinjection to single cells has been widely used in the studies of transduction-challenged cells, transgenic animal production, and in vitro fertilization to mechanically transfer DNAs, RNA interferences, sperms, proteins, peptides, and drugs. The advantages of microinjection include the precision of delivery dosage and timing, high efficiency of transduction as well as low cytotoxicity. However, manual microinjection is labor intensive and time consuming, which limits the application of this technique to large number of cells in a sample. New cell culture matrix ensuring all cells grow in a desired position and orientation is needed for application of high throughput automatic injection systems, which will significantly increase injection speed, cell survival, and success rates.


Asunto(s)
Sistemas de Liberación de Medicamentos/instrumentación , Sistemas de Liberación de Medicamentos/métodos , Técnicas de Transferencia de Gen/instrumentación , Microinyecciones/instrumentación , Microinyecciones/métodos , Sistemas de Liberación de Medicamentos/tendencias , Técnicas de Transferencia de Gen/tendencias , Fenómenos Mecánicos , Microinyecciones/tendencias
7.
Prog Neurobiol ; 83(3): 131-9, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17889422

RESUMEN

Extracellular amyloid beta (Abeta) that confers neurotoxicity and modulates synaptic plasticity and memory function has been central to the amyloid hypothesis of Alzheimer's disease (AD) pathology. Like many other misfolded proteins identified in neurodegenerative disorders, Abeta also accumulates inside the AD neurons. This intracellular Abeta affects a variety of cellular physiology from protein degradation, axonal transport, autophagy to apoptosis, further documenting the role of Abeta in AD. Therapeutics targeting intracellular Abeta could be effective treatment for AD.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Líquido Intracelular/metabolismo , Neuronas/citología , Enfermedad de Alzheimer/patología , Animales , Humanos , Neuronas/metabolismo , Neuronas/patología
8.
Neuroscientist ; 14(6): 561-70, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18349442

RESUMEN

Morphine has received intensive research interest for a long time. However, until recently, the protective versus destructive roles of morphine in the neuronal system have not been studied. There is evidence suggesting that morphine induces apoptotic cell death in neuronal and glial cells, whereas controversial studies support a neuroprotective role for morphine. The exact mechanisms for both protective and destructive pathways are not clear and are still under investigation. Improved understanding of morphine neuroprotection and neurotoxicity will be helpful to control morphine side effects in medical applications and to identify new targets for potential therapies and prevention strategies to opioid addiction.


Asunto(s)
Apoptosis/efectos de los fármacos , Morfina/farmacología , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Animales , Humanos , Modelos Biológicos , Síndromes de Neurotoxicidad/patología , Síndromes de Neurotoxicidad/prevención & control
9.
Regul Pept ; 151(1-3): 43-7, 2008 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-18588920

RESUMEN

Nociceptin/orphanin FQ (N/OFQ) is a heptadecapeptide, which has been identified as an endogenous ligand of the opioid receptor-like (ORL1) receptor. The present study investigated the nociceptive effect of intra-nucleus accumbens (intra-NAc) injection of OFQ, and the involvement of ERK pathway in such effect. Intra-NAc injection of OFQ (0.1, 0.5, 1 nmol) dose-dependently decreased the nociceptive thresholds on the hindpaw withdrawal response to thermal and mechanical stimulation in rats. Moreover, the intra-NAc injection of OFQ-induced decreases in HWLs were antagonized by intra-NAc injection of (Nphe(1))nociceptin(1-13)NH(2), an antagonist of ORL1 receptor, in a dose-dependent way. Furthermore, the OFQ-induced nociception could be attenuated by pretreatment with the mitogen-activated protein kinase/ERK kinase (MEK) inhibitor 1,4-diamino-2,3-dicyano-1,4-bis(2-aminopheylthio)butadiene (U0126). Our results demonstrate that OFQ induces nociceptive effects in NAc. The effect was blocked by the antagonist (Nphe(1))nociceptin(1-13)NH(2) and attenuated by U0126, suggesting that the activation of ERK pathways is involved in the OFQ-induced nociceptive effect in the NAc of rats.


Asunto(s)
Sistema de Señalización de MAP Quinasas , Nociceptores/efectos de los fármacos , Nociceptores/fisiología , Núcleo Accumbens/efectos de los fármacos , Núcleo Accumbens/fisiología , Péptidos Opioides/administración & dosificación , Receptores Opioides/fisiología , Animales , Butadienos/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Nitrilos/farmacología , Péptidos Opioides/farmacología , Dimensión del Dolor , Fragmentos de Péptidos/farmacología , Ratas , Ratas Wistar , Receptor de Nociceptina , Nociceptina
10.
Neurochem Res ; 33(10): 2112-7, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18461445

RESUMEN

The central nervous system (CNS) is highly dependent on adequate supply of oxygen and is sensitive to hypoxia. It is known that hypoxia induces injuries on the brain tissue and the neuronal activity. Curcumin, a yellow pigment obtained from the rhizome of C. longa Linn., has been regarded as a multi-functional drug with antioxidative activity. In the present study, we first demonstrated a significant decrease in the content of beta-III tubulin protein in rat prefrontal cortex (PFC) tissues induced by repeated hypoxia, but not in rat cerebellum tissue. These suggest a relatively higher sensitivity and probably a higher vulnerability of rat PFC tissue to hypoxia in vivo. We reconfirmed the effect of hypoxia to primary cultured neurons from rat PFC and found a significant decrease in the contents of beta-III tubulin protein after chronic exposure to hypoxia. Moreover, we demonstrated that the hypoxia-induced decrease in beta-III tubulin protein content could be restored by curcumin, suggesting a potential protection of curcumin against hypoxia-induced decreases in beta-III tubulin content in rat PFC neurons.


Asunto(s)
Curcumina/farmacología , Hipoxia Encefálica/fisiopatología , Corteza Prefrontal/metabolismo , Tubulina (Proteína)/metabolismo , Animales , Células Cultivadas , Masculino , Neuronas/metabolismo , Corteza Prefrontal/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
11.
Neurosci Lett ; 444(3): 236-9, 2008 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-18722507

RESUMEN

The present study was performed to investigate the possible protective effects of green tea polyphenols against ultraviolet (UV)-C light irradiation-induced cell death in the cultured rat cortical neurons. We found that UV-C light irradiation induced marked cell death tested by 3-(4,5-Dimethylthiazole-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and TdT-mediated biotin-dUTP nicked-end labeling (TUNEL) assay. Protective effects of green tea polyphenols on UV-C light irradiation-induced apoptosis in cortical neurons were demonstrated by testing the content of Bax, which is involved in cell death. The expression of active Bax in cultured rat cortical neurons was inhibited significantly by green tea polyphenols compared to UV irradiation group tested by the immunoprecipitation assay and Western blot assay. However, there were no significant changes in the contents of total Bax after treatment with green tea polyphenols in UV-C light-irradiated rat cortical neurons. Our results demonstrated that the green tea polyphenols inhibited the active Bax expression, suggesting a neuroprotective effect of green tea polyphenols against the UV-C light irradiation-induced injury on cortical neurons.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Flavonoides/farmacología , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Fenoles/farmacología , , Rayos Ultravioleta/efectos adversos , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/citología , Corteza Cerebral/efectos de la radiación , Neuronas/citología , Neuronas/efectos de la radiación , Polifenoles , Ratas , Proteína X Asociada a bcl-2/metabolismo
12.
Neurosci Lett ; 441(3): 311-4, 2008 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-18601975

RESUMEN

Morphine has been used for pain treatment with a long history. Some data suggest that morphine is toxic to neurons and induces apoptosis, while other evidence shows that morphine could have beneficial effects against cell death. To determine how morphine affects pro-apoptotic protein Bax and molecular chaperone Hsp70, different concentrations of morphine were examined. Our results show that prolonged morphine administration for 5 days at 1microM concentration protects against serum deprivation induced cell death in rat primary neurons. Morphine treatment decreases Bax and Hsp70 levels in cultured rat primary neurons, suggesting morphine may have a protective role in staurosporine and serum deprivation induced cytotoxicity.


Asunto(s)
Apoptosis/efectos de los fármacos , Proteínas del Choque Térmico HSP72/metabolismo , Morfina/farmacología , Neuronas Aferentes/metabolismo , Fármacos Neuroprotectores/farmacología , Proteína X Asociada a bcl-2/metabolismo , Analgésicos Opioides/metabolismo , Analgésicos Opioides/farmacología , Animales , Animales Recién Nacidos , Apoptosis/fisiología , Proteínas Reguladoras de la Apoptosis/efectos de los fármacos , Proteínas Reguladoras de la Apoptosis/metabolismo , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Encéfalo/citología , Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Células Cultivadas , Medio de Cultivo Libre de Suero/toxicidad , Citoprotección/efectos de los fármacos , Citoprotección/fisiología , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Inhibidores Enzimáticos/toxicidad , Proteínas del Choque Térmico HSP72/efectos de los fármacos , Morfina/metabolismo , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Neuronas Aferentes/efectos de los fármacos , Fármacos Neuroprotectores/metabolismo , Ratas , Estaurosporina/toxicidad , Proteína X Asociada a bcl-2/efectos de los fármacos
13.
Behav Brain Res ; 179(2): 331-5, 2007 May 16.
Artículo en Inglés | MEDLINE | ID: mdl-17383023

RESUMEN

The hindpaw withdrawal latencies (HWLs) to noxious thermal and mechanical stimulation increased significantly after intra-hypothalamic arcuate nucleus (ARC) injection of galanin in mononeuropathic rats, while intra-ARC injection of the putative antagonist of galanin receptors markedly reduced the HWLs. The number of galaninergic neurons in the ARC increased in rats with mononeuropathy than that in normal rats. The results demonstrated that both endogenous and exogenous galanin were involved in the regulation of nociception in the ARC of rats with peripheral nerve injury.


Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Galanina/fisiología , Mononeuropatías/metabolismo , Umbral del Dolor/fisiología , Tiempo de Reacción/fisiología , Animales , Masculino , Ratas , Ratas Wistar
14.
J Pain ; 8(1): 85-90, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17097925

RESUMEN

UNLABELLED: Antinociceptive effects of oxytocin have been demonstrated in mice, rats, dogs, and humans. It has been shown that oxytocin receptors and fibers with oxytocin were distributed in the nucleus accumbens (NAc) of rats. The present study was performed to investigate the regulating role of oxytocin in nociception in the NAc of rats. Intra-NAc administration of oxytocin-induced dose-dependent increases in the hindpaw withdrawal latency (HWL) to noxious thermal and mechanical stimulation in rats, indicating that oxytocin has antinociceptive effects in the NAc of rats. Furthermore, the oxytocin-induced antinociceptive effects were attenuated by intra-NAc administration of the opioid-receptor antagonist naloxone, suggesting that the endogenous opioid system is involved in the oxytocin-induced antinociception in the NAc. Moreover, the oxytocin-induced antinociception was attenuated by intra-NAc injection of the kappa-receptor antagonist nor-binaltorphimine (nor-BNI) and the mu-receptor antagonist beta-funaltrexamine, but not by the delta-receptor antagonist naltrindole, demonstrating the involvements of mu- and kappa-receptors, but not delta-receptor, in the oxytocin-induced antinociception in the NAc of rats. PERSPECTIVE: This article supplements the evidence that oxytocin regulates nociception in the central nervous system. It presents additional material for clinical application of oxytocin as an analgesia drug.


Asunto(s)
Analgésicos , Núcleo Accumbens/efectos de los fármacos , Oxitocina/farmacología , Receptores Opioides/efectos de los fármacos , Animales , Calor , Masculino , Microinyecciones , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Núcleo Accumbens/metabolismo , Oxitocina/administración & dosificación , Oxitocina/antagonistas & inhibidores , Dimensión del Dolor/efectos de los fármacos , Estimulación Física , Ratas , Ratas Wistar , Receptores Opioides/metabolismo , Receptores Opioides delta/efectos de los fármacos , Receptores Opioides kappa/efectos de los fármacos , Receptores Opioides mu/efectos de los fármacos
15.
Neurosci Lett ; 414(3): 237-41, 2007 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-17287081

RESUMEN

Both the calcitonin gene-related peptide (CGRP) receptor and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor are involved in the transmission of sensory information from primary afferent to the spinal cord. The present study found that there was a colocalization of CGRP receptor and AMPA receptor in a single spinal dorsal horn neuron in rat determined by double immunofluorescence labeling image methods. Furthermore, our results showed that the evoked discharge frequency of the wide dynamic range (WDR) neuron, one type of the dorsal horn neurons, increased significantly after micro-iontophoretic delivery of CGRP or AMPA alone tested by extracellular recording, indicating a functional colocalization of CGRP receptor and AMPA receptor in a single spinal dorsal horn neuron. The results of the present study found a morphological and functional colocalization of the CGRP receptor and AMPA receptor in a single dorsal horn neuron that involved in the transmission and modulation of sensory information from primary afferent to the spinal cord in rats.


Asunto(s)
Vías Aferentes/metabolismo , Células del Asta Posterior/metabolismo , Receptores AMPA/metabolismo , Receptores de Péptido Relacionado con el Gen de Calcitonina/metabolismo , Raíces Nerviosas Espinales/metabolismo , Transmisión Sináptica/fisiología , Vías Aferentes/anatomía & histología , Vías Aferentes/efectos de los fármacos , Animales , Péptido Relacionado con Gen de Calcitonina/metabolismo , Péptido Relacionado con Gen de Calcitonina/farmacología , Potenciales Evocados , Agonistas de Aminoácidos Excitadores/farmacología , Técnica del Anticuerpo Fluorescente , Ácido Glutámico/análogos & derivados , Ácido Glutámico/metabolismo , Masculino , Nociceptores/citología , Nociceptores/efectos de los fármacos , Nociceptores/metabolismo , Dolor/metabolismo , Dolor/fisiopatología , Células del Asta Posterior/citología , Células del Asta Posterior/efectos de los fármacos , Ratas , Ratas Wistar , Receptores AMPA/efectos de los fármacos , Receptores de Péptido Relacionado con el Gen de Calcitonina/efectos de los fármacos , Sensación/efectos de los fármacos , Sensación/fisiología , Raíces Nerviosas Espinales/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacos , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/farmacología
16.
Neurosci Lett ; 426(3): 135-8, 2007 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-17904288

RESUMEN

The present study was performed to investigate the effects of valproic acid sodium (VPA), a widely utilized antiepileptic drug, on the establishment of chronic morphine-induced conditioned place preference (CPP). The rat model of morphine-induced CPP was conditioned with alternating intracerebroventricular (i.c.v.) injections of morphine (60 microg/6 microl) and saline for 5 days. To investigate the influence of VPA on morphine-induced CPP, rats received chronic pretreatment of i.c.v. VPA (500 microg/rat) 10 min previous to the daily morphine injection. The results demonstrated that the morphine-induced CPP was significantly attenuated by VPA pretreatment, while the VPA itself could not induce any CPP or conditioned place aversion (CPA) effects. The results of the present study not only confirmed the reliability of establishing morphine-induced CPP model by i.c.v. injection, but also suggest that the antiepileptic drug VPA may be utilized as potential therapeutic medications for drug abuse in the future.


Asunto(s)
Encéfalo/efectos de los fármacos , Condicionamiento Clásico/efectos de los fármacos , GABAérgicos/administración & dosificación , Morfina/administración & dosificación , Narcóticos/administración & dosificación , Ácido Valproico/administración & dosificación , Animales , Conducta Animal/efectos de los fármacos , Inyecciones Intraventriculares , Masculino , Dependencia de Morfina/fisiopatología , Ratas , Ratas Wistar
17.
Neurosci Lett ; 638: 156-161, 2017 01 18.
Artículo en Inglés | MEDLINE | ID: mdl-27993710

RESUMEN

The present study was performed to explore the role of galanin in nociceptive modulation in anterior cingulate cortex (ACC) of rats with acute inflammation, and the changes in galanin and galanin receptor 2 (Gal R2) expressions in rats with acute inflammation. Intra-ACC injection of galanin induced antinociception in rats with acute inflammation, the antinociceptive effects induced by galanin were attenuated significantly by intra-ACC injection of the Gal R2 antagonist M871, indicating an involvement of Gal R2 in nociceptive modulation in ACC in rats with acute inflammation. Furthermore, we found that both the galanin mRNA expression and galanin content increased significantly in ACC in rats with acute inflammation than that in normal rats. Moreover, both the mRNA levels of Gal R2 and the content of Gal R2 in ACC increased significantly in rats with acute inflammation than that in normal rats. These results demonstrated that galanin induced antinociception in ACC in rats with acute inflammation. And there were changes in the expression of galanin and Gal R2 in rats with acute inflammation.


Asunto(s)
Galanina/metabolismo , Giro del Cíngulo/metabolismo , Inflamación/fisiopatología , Nocicepción , Enfermedad Aguda , Analgésicos/farmacología , Animales , Galanina/genética , Galanina/farmacología , Giro del Cíngulo/efectos de los fármacos , Calor , Hiperalgesia/metabolismo , Hiperalgesia/fisiopatología , Inflamación/metabolismo , Masculino , Nocicepción/efectos de los fármacos , Dolor/metabolismo , Dolor/fisiopatología , Estimulación Física , ARN Mensajero/metabolismo , Ratas Sprague-Dawley , Receptor de Galanina Tipo 2/antagonistas & inhibidores , Receptor de Galanina Tipo 2/metabolismo
18.
Sci Rep ; 7: 45930, 2017 04 05.
Artículo en Inglés | MEDLINE | ID: mdl-28378856

RESUMEN

The present study was performed to explore the role of galanin and galanin receptor 2 in nociceptive modulation in anterior cingulate cortex (ACC) of normal rats and rats with mononeuropathy. Intra-ACC injection of galanin induced significant increases in hindpaw withdrawal latencies (HWLs) to thermal and mechanical stimulations in both normal rats and rats with mononeuropathy, the increased HWLs were attenuated significantly by intra-ACC injection of galanin receptor 2 antagonist M871, indicating an involvement of galanin receptor 2 in nociceptive modulation in ACC. Interestingly, the galanin-induced HWL was significant higher in rats with mononeuropathy than that in normal rats tested by Randall Selitto test. Furthermore, both the galanin mRNA expression and galanin content increased significantly in ACC in rats with mononeuropathy than that in normal rats. Moreover, both the mRNA levels of galanin receptor 2 and the content of galanin receptor 2 in ACC increased significantly in rats with mononeuropathy than that in normal rats. These results found that galanin induced antinociception in ACC in both normal rats and rats with mononeuropathy. And there may be plastic changes in the expression of galanin and galanin receptor 2 in rats with mononeuropathy, as well as in the galanin-induced antinociception.


Asunto(s)
Galanina/metabolismo , Giro del Cíngulo/metabolismo , Mononeuropatías/metabolismo , Nociceptores/metabolismo , Precursores de Proteínas/metabolismo , Receptor de Galanina Tipo 2/metabolismo , Animales , Galanina/genética , Galanina/farmacología , Expresión Génica/efectos de los fármacos , Giro del Cíngulo/efectos de los fármacos , Giro del Cíngulo/fisiopatología , Miembro Posterior , Masculino , Mononeuropatías/genética , Mononeuropatías/fisiopatología , Nocicepción/efectos de los fármacos , Dolor Nociceptivo/genética , Dolor Nociceptivo/metabolismo , Dolor Nociceptivo/fisiopatología , Nociceptores/efectos de los fármacos , Dimensión del Dolor/métodos , Péptidos/farmacología , Precursores de Proteínas/genética , Precursores de Proteínas/farmacología , Ratas Sprague-Dawley , Receptor de Galanina Tipo 2/antagonistas & inhibidores , Receptor de Galanina Tipo 2/genética
19.
Sci Rep ; 7(1): 15317, 2017 11 10.
Artículo en Inglés | MEDLINE | ID: mdl-29127424

RESUMEN

The present study was performed to explore the role of galanin and galanin receptor 1 (GalR 1) in nociceptive modulation in the central nucleus of amygdala (CeA) in normal rats and rats with neuropathy, and the involvement of GalR 1 and PKC was also investigated. The hindpaw withdrawal latencies (HWLs) to thermal and mechanical stimulations were increased in a dose-dependent manner after intra-CeA injection of galanin in both normal rats and rats with neuropathy. The increased HWLs were significantly attenuated by intra-CeA injection of galanin receptor antagonist M40, indicating an involvement of galanin receptor in nociceptive modulation in CeA. Furthermore, intra-CeA administration of the GalR 1 agonist M 617 induced increases in HWLs in normal rats, suggesting that GalR 1 may be involved in galanin-induce antinociception in CeA. Additionally, intra-CeA injection of the PKC inhibitor inhibited galanin-induced antinociception, showing an involvement of PKC in galanin-induced antinociception in CeA of normal rats. Moreover, there was a significant increase in GalR1 content in CeA in rats with neuropathy than that in normal rats. These results illustrated that galanin induced antinociception in CeA in normal rats and rats with neuropathy, and there is an up-regulation of GalR1 expression in rats with neuropathy.


Asunto(s)
Bradiquinina/análogos & derivados , Núcleo Amigdalino Central/metabolismo , Galanina/análogos & derivados , Galanina/antagonistas & inhibidores , Neuralgia/metabolismo , Nocicepción/efectos de los fármacos , Fragmentos de Péptidos/farmacología , Receptor de Galanina Tipo 1/metabolismo , Animales , Bradiquinina/farmacología , Núcleo Amigdalino Central/patología , Núcleo Amigdalino Central/fisiopatología , Galanina/metabolismo , Galanina/farmacología , Masculino , Neuralgia/tratamiento farmacológico , Neuralgia/patología , Neuralgia/fisiopatología , Ratas , Ratas Sprague-Dawley
20.
Behav Brain Res ; 173(1): 116-21, 2006 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-16837074

RESUMEN

Cholecystokinin (CCK) is an endogenous anti-opioid peptide in the central nervous system. The present study investigated the effects of endogenous CCK on tolerance to morphine antinociception in the nucleus accumbens (NAc) of rats. Chronic administration of morphine to NAc induced marked tolerance to antinociception. Intra-NAc administration of the CCK2 receptor antagonist LY225910 inhibited not only the development but also the expression of chronic morphine-induced antinociceptive tolerance. However, intra-NAc injection of LY225910 did not influence the antinociception induced by intra-NAc administration of morphine in the intact rats. The results indicate that endogenous CCK plays an important role in morphine-induced antinociceptive tolerance in the NAc of rats.


Asunto(s)
Analgésicos Opioides/farmacología , Colecistoquinina/fisiología , Tolerancia a Medicamentos/fisiología , Morfina/farmacología , Núcleo Accumbens/metabolismo , Umbral del Dolor/efectos de los fármacos , Análisis de Varianza , Animales , Colecistoquinina/efectos de los fármacos , Masculino , Núcleo Accumbens/efectos de los fármacos , Umbral del Dolor/fisiología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA